And"inhibition" It aims to inhibit the work of an organ in the body, or an enzyme, by preventing the completion of a reaction, activity or function.
During a study conducted on dozens of patients with different types of cancer Which is difficult to treat, the drug was able to stop the growth of cancer I have eight patients.
Of these, two had pancreatic cancer, three had colon cancer, one had lung cancer, and one had salivary gland cancer.
Scientists say normal cells do Protein Only when it is time to multiply reverse the cancer cells that produce them in large quantities and constantly, resulting "unbalanced growth".
The lead author of the study, Dr. Elena Garalda, director of the Early Drug Development Unit at the Vall d’Hebron Institute of Oncology (VHIO) in California, explained. Barcelona: "MYC is one of the most in demand targets in the cancer field".
added: "this gene It plays a key role in guiding and maintaining many cancers common to humans, such as breast, prostate, lung, and ovary.".
Following: "So far, none have been approved medicinal The MYC gene is prevented from starting clinical trials".
“>
The source said so treatmentOMO-103, known as OMO-103, works by inhibiting the MYC gene, which regulates the messages that instruct cells to divide and grow.
And “inhibition” means to inhibit the work of an organ in the body, or an enzyme, preventing the completion of a reaction, activity or function.
During a study conducted on dozens of patients with different types of cancer Which is difficult to treat, the drug was able to stop the growth of cancer I have eight patients.
Of these, two had pancreatic cancer, three had colon cancer, one had lung cancer, and one had salivary gland cancer.
Scientists say normal cells do Protein Only when it is time to multiply the cancer cells that produce them in large quantities and constantly reverse, resulting in “unbalanced growth”.
The lead author of the study, Dr. Elena Garalda, director of the Early Drug Development Unit at the Vall d’Hebron Institute of Oncology (VHIO) in California, explained. Barcelona: “MYC is one of the most sought after targets in cancer”.
He added: “This gene It plays a key role in the guidance and maintenance of many cancers common to humans, such as breast, prostate, lung and ovary ”.
And he continued: “So far, no approval has been given medicinal The MYC gene is prevented from starting clinical trials. “
